Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on October 20, 2026

Oct. 20, 2026

Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study

Indeterminate GlobeNewswire

Oct. 20, 2026

Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia

Indeterminate GlobeNewswire

Oct. 20, 2026

Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young

Indeterminate GlobeNewswire

Oct. 20, 2026

ABBYY Introduces PHOENIX Plus, Advanced AI Models Optimized for Intelligent Document Processing

Indeterminate GlobeNewswire

Oct. 20, 2026

Abiologics Appoints Per Jr. Greisen as Chief Artificial Intelligence Officer

Indeterminate GlobeNewswire

Oct. 20, 2026

Matternet Expands NHS Drone Delivery Network to Great Ormond Street Hospital

Indeterminate GlobeNewswire

Oct. 20, 2026

Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

BioNTech veröffentlicht am 3. November 2026 Ergebnisse für das dritte Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire

Oct. 20, 2026

BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy

Indeterminate GlobeNewswire

Oct. 20, 2026

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study

Indeterminate GlobeNewswire

Oct. 20, 2026

Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania

Indeterminate GlobeNewswire

Oct. 20, 2026

Maxion Therapeutics Appoints Biopharma Leader Mikael Dolsten to Board of Directors

Indeterminate GlobeNewswire

Oct. 20, 2026

Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week 2026

Indeterminate GlobeNewswire

Oct. 20, 2026

KFSH Brings Cardiac Catheterization Directly to Emergency Department to Accelerate Critical Care

Indeterminate GlobeNewswire

Oct. 20, 2026

Aqua free erweitert Produktportfolio: Neuer Baclyser® neo T Max für noch mehr Kapazität und Effizienz

Indeterminate GlobeNewswire

Oct. 20, 2026

Aqua free expands its product portfolio: New Baclyser® neo T Max offers greater capacity and efficiency

Indeterminate GlobeNewswire

Oct. 20, 2026

Aqua free élargit sa gamme de produits : le nouveau Baclyser® neo T Max pour une capacité et une efficacité accrues

Indeterminate GlobeNewswire

Oct. 20, 2026

Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch

Indeterminate GlobeNewswire